SpyGlass Pharma has named Shannon Treviño as its new general counsel. Treviño brings extensive legal and leadership experience, having previously guided Inari Medical through a $4.9 billion acquisition. Her appointment comes as SpyGlass advances its BIM-IOL System through Phase 3 clinical trials, aiming for FDA approval and commercialization. This move strengthens SpyGlass's leadership as it develops innovative treatments for chronic eye conditions.
Purpose Investments has declared distributions for June 2026 across its variable and fixed capital ETFs and funds. The ex-distribution date for variable capital funds is June 26, 2026, and for fixed capital funds, June 30, 2026. Distributions cover a...
Wayne Jobson, a Grammy-winning producer and filmmaker, discussed his career and influence on reggae and mainstream music in a recent Echoes Across Time podcast. He highlighted his work with Bob Marley, No Doubt, and contributions to major film soundt...
Batmobile Racing has revealed a striking new car design for the Lamborghini Super Trofeo Asia race at Fuji Speedway, supported by new partnerships with Fasoul and Lightec. Leading the Pro category, drivers William Tregurtha and Jonathan Cecotto aim t...
Batmobile Racing has launched a bold new livery for their Car #3, backed by partnerships with Fasoul and Lightec, for the Lamborghini Super Trofeo Asia round at Fuji Speedway. Leading the Pro category, drivers William Tregurtha and Jonathan Cecotto a...
Fluency has issued a notice advising journalists and readers to disregard its previous news release from June 11, 2026, which claimed that CVS was using Fluency to close an enterprise AI deployment gap. This retraction suggests the earlier announceme...
